4
Changes in Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0001209191-22-038201
Options or other derivatives
- Director acquired 53,700 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Kunkel Lori Anne Director | 2022-06-17 | Grant or award · Stock Option (right to buy) | +53,700 | 53,700 | D | ||
Loading xslF345X03/doc4.xml…